Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
A6NMB9
UPID:
FIGL2_HUMAN
Alternative names:
-
Alternative UPACC:
A6NMB9
Background:
Fidgetin-like protein 2, encoded by the gene with the accession number A6NMB9, plays a crucial role in cellular processes. Its specific functions, while not fully elucidated, are believed to be pivotal in maintaining cellular integrity and function. The protein's unique structure and biochemical properties make it an intriguing subject for scientific inquiry, suggesting its involvement in critical biological pathways.
Therapeutic significance:
Understanding the role of Fidgetin-like protein 2 could open doors to potential therapeutic strategies. While direct associations with diseases are yet to be established, the protein's fundamental role in cellular processes hints at its potential impact on disease mechanisms. Exploring its functions further could lead to breakthroughs in treating conditions that currently lack effective therapies.